On Sunday, Jan. 1, Walgreens' contract with Express Scripts expired, and millions of Walgreens customers covered by ESI were forced to either move their pharmacy business to another pharmacy in the Express Script network or come up with some other way to stick with Walgreens. DSN editor Rob Eder on Tuesday interviewed Walgreens president and CEO Greg Wasson on what the company is doing to hold on to those customers and to appeal to payers, and what the potential ESI-Medco deal could mean.
Haggen’s acquisition of 146 Albertsons and Safeway stores is shaping up as a disaster and the reasons why are detailed in a new lawsuit that puts the blame squarely on the parent company — Albertsons Holdings — of the divested stores.
How serious are Rite Aid’s leaders when they proclaim their determination to make the company a full-service, full-spectrum retail healthcare provider? Serious enough to buy RediClinic — which has operated walk-in healthcare clinics in roughly 30 H-E-B stores in Texas for much of the past decade — and serious enough to embark on an aggressive growth campaign that includes the clinic healthcare provider as a new Rite Aid subsidiary.
The gummy sub-segment within overall vitamins is not only still growing substantially, the dollar volume of that alternative delivery format has reached nowhere near its ceiling of potential, at least not yet. Overall, sales of vitamins for the 52 weeks ended Dec. 28, 2014, were up 0.4% to $6.5 billion across total U.S. multi-outlets, according to IRI.
Taiwan-based drug development company Sunny Pharmtech and Vitruvias Therapeutics, a generic drug development company, on Tuesday announced that they will team up to co-develop a portfolio of generic drug products.